## **Core Concept**
Pseudomonas aeruginosa is a gram-negative bacterium known for causing urinary tract infections (UTIs), particularly in hospitalized patients or those with underlying conditions. Effective treatment of Pseudomonas UTIs requires antibiotics with reliable activity against this organism.

## **Why the Correct Answer is Right**
The correct answer, **Ceftazidime**, is a third-generation cephalosporin with potent activity against Pseudomonas aeruginosa. It works by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins (PBPs), ultimately leading to cell lysis and death. Ceftazidime is often used for serious infections caused by Pseudomonas, including UTIs, due to its efficacy and relatively favorable resistance profile.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Ampicillin is a broad-spectrum penicillin but has limited activity against Pseudomonas aeruginosa, making it a less suitable choice for treating UTIs caused by this organism.
- **Option B:** Ciprofloxacin, a fluoroquinolone, does have activity against Pseudomonas but resistance rates can be high in some areas, making it less reliable as an empirical choice without susceptibility data.
- **Option D:** Gentamicin is an aminoglycoside with activity against Pseudomonas but is generally reserved for more severe infections or when used in combination with other agents due to its potential for nephrotoxicity and ototoxicity.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **Pseudomonas aeruginosa** infections often require antibiotics with specific activity against this organism, such as ceftazidime, cefepime, or piperacillin-tazobactam. Susceptibility testing is crucial to guide therapy.

## **Correct Answer:** . Ceftazidime